Meet the jury: prof. Isabelle Savary Auzeloux and prof. Jürgen Bauer
You are kindly invited to the Meet the jury lectures of prof. Isabelle Savary Auzeloux and prof. Jürgen Bauer.
Date: 27 May 2026 13h00
Location: Aula Erik De Clercq, Rega Institute, Campus Gasthuisberg
Prof. Dr. Isabelle Savary-Auzeloux on “Nutritional strategies capable of limiting sarcopenia and associated conditions in older persons. Examples of translational studies carried out at the Human Nutrition Unit Clermont Ferrand”.
About the lecture
Prof. Savary-Auzeloux will discuss the role of dietary protein and gut-targeted nutritional strategies – including pre-, pro- and postbiotics – in limiting age-related muscle loss, drawing on translational research conducted within her own research group.
About the speaker
Prof. Dr. Isabelle Savary-Auzeloux is a Senior Researcher at the Unité de Nutrition Humaine (UNH), INRAE and Université Clermont Auvergne (France), where she is a member of the IMPROVING research team. Her research focuses on dietary protein intake and gut-targeted nutritional strategies – including pro- and prebiotics – as means to limit sarcopenia and associated metabolic dysregulation in older adults. Her current work combines these approaches through the study of fermented foods within the PIMENTO COST Action and the Horizon Europe DOMINO project.
Key publications
- Lacticaseibacillus casei CNCM I-5663 supplementation maintained muscle mass in a model of frail rodents; Giron M, Thomas M, Jarzaguet M, Mayeur C, Ferrere G, Noordine ML, Bornes S, Dardevet D, Chassard C, Savary-Auzeloux I. Lacticaseibacillus casei CNCM I-5663 supplementation maintained muscle mass in a model of frail rodents. Front Nutr. 2022 Aug 10;9:928798. doi: 10.3389/fnut.2022.928798. Erratum in: Front Nutr. 2023 Jan 04;9:1109835. doi: 10.3389/fnut.2022.1109835. PMID: 36034910; PMCID: PMC9399775.
- Gut microbes and muscle function: can probiotics make our muscles stronger, Giron M, Thomas M, Dardevet D, Chassard C, Savary-Auzeloux I. Gut microbes and muscle function: can probiotics make our muscles stronger? J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1460-1476. doi: 10.1002/jcsm.12964. Epub 2022 Mar 12. PMID: 35278043; PMCID: PMC9178375.
- Anti-inflammatory Streptococcus thermophilus CNRZ160 limits sarcopenia induced by low-grade inflammation in older adults rats; Savary-Auzeloux I, Jarzaguet M, Migné C, Kemeny JL, Novais-Gameiro L, de Azevedo M, Mathé V, Mariotti F, Langella P, Chatel JM, Dardevet D. Anti-inflammatory Streptococcus thermophilus CNRZ160 limits sarcopenia induced by low-grade inflammation in older adult rats. Front Nutr. 2022 Sep 29;9:986542. doi: 10.3389/fnut.2022.986542. PMID: 36245508; PMCID: PMC9559730.
Prof. Dr. Jürgen Bauer on “Future prevention and therapy of frailty and sarcopenia – Is technology key?”
About the lecture
In this lecture, Prof. Bauer will explore the future landscape of frailty and sarcopenia prevention and treatment, discussing how technology may be an enabler in this context. He will also present findings from recently completed clinical trials from his own research group.
About the speaker
Professor Bauer is a geriatrician and Medical Director of the Geriatric Centre at Heidelberg University Hospital and the Agaplesion Bethanien-Krankenhaus Heidelberg, as well as Director of the Network Aging Research (NAR) at Heidelberg University. His work has fundamentally shaped our understanding of sarcopenia, frailty, and the role of nutritional intervention in maintaining function and quality of life in older adults, influencing both clinical practice and international guidelines including those of European Society for Clinical Nutrition and Metabolism (ESPEN) and European Working Group on Sarcopenia in Older People (EWGSOP).
Key publications
- Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group; Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, Phillips S, Sieber C, Stehle P, Teta D, Visvanathan R, Volpi E, Boirie Y. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013 Aug;14(8):542-59. doi: 10.1016/j.jamda.2013.05.021. Epub 2013 Jul 16. PMID: 23867520.
- Experts’ preferences for sarcopenia outcomes: a discrete-choice experiments from a working group of the European society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society; Beaudart C, Bauer JM, Landi F, Bruyère O, Reginster JY, Hiligsmann M; ESCEO Working Group on Sarcopenia, Sarcopenia Interest Group of the EUGMS. Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS). Aging Clin Exp Res. 2021 Apr;33(4):1079-1083. doi: 10.1007/s40520-021-01794-2. Epub 2021 Mar 5. PMID: 33666899; PMCID: PMC8084829.
- Sarcopenia: A Time for Action. An SCWD Position Paper: Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, Baracos VE, Crawford JA, Doehner W, Heymsfield SB, Jatoi A, Kalantar-Zadeh K, Lainscak M, Landi F, Laviano A, Mancuso M, Muscaritoli M, Prado CM, Strasser F, von Haehling S, Coats AJS, Anker SD. Sarcopenia: A Time for Action. An SCWD Position Paper. J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):956-961. doi: 10.1002/jcsm.12483. Epub 2019 Sep 15. PMID: 31523937; PMCID: PMC6818450.
Contact: Laurence<dot>lapauw<at>kuleuven<dot>be